Literature DB >> 1898338

Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension.

M Cluzel1, C A Rohde, D W MacGlashan, B J Undem, F H Chilton.   

Abstract

The present study has examined the dynamics of platelet-activating-factor (PAF) synthesis, release and uptake in order to understand better the trafficking of PAF between cells and medium. Initial experiments indicated that the amount of PAF found on the outside of the cell remained constant well after the synthesis from a precursor had apparently stopped, and in spite of a continued capacity of the cell to take up and catabolize PAF. These results suggested that PAF produced and stored within the cell is eventually released to the outside of the cell at a rate proportional to that of cellular uptake. In order to estimate the amount of PAF released from the cell, the processes of PAF release and uptake were modelled using simple mathematical functions. It was found that, under the experimental conditions used in this study, the uptake of PAF could be expressed as an exponential function tending to a non-zero baseline. Utilizing this rate constant for the uptake of PAF with the amount of PAF outside the cell, the amount of total PAF released from the cell was estimated. Data from the model suggested PAF was released in amounts 10-fold higher than could actually be measured over 30 min. In fact, the model predicted more PAF could be released from the cell than is synthesized, suggesting that a portion of the PAF which is released is taken up and then released again to the outside of the cell. The potential for PAF and/or its intermediates to be recycled was verified by demonstrating that a large proportion of exogenously provided 1-alkyl-2-lyso-sn-glycero-3-phosphocholine is taken up by the neutrophil, converted into PAF and then released again by the cell. These results suggest that PAF trafficking between the cell and medium is complex and involves many processes, which include synthesis, release, uptake, catabolism and recycling.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898338      PMCID: PMC1151365          DOI: 10.1042/bj2780453

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

3.  The intracellular retention of newly synthesized platelet-activating factor.

Authors:  J M Lynch; P M Henson
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

Review 4.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).

Authors:  M Triggiani; F H Chilton
Journal:  Biochim Biophys Acta       Date:  1989-11-06

Review 6.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

7.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.

Authors:  M Cluzel; B J Undem; F H Chilton
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

9.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

10.  1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil.

Authors:  F H Chilton; T R Connell
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.